ARCH Venture Fund VII, L.P. 13D/13G Filings for Unity Biotechnology, Inc. (UNBX)

ARCH Venture Fund VII, L.P. 13D and 13G filings for Unity Biotechnology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-14
4:30 pm
Unchanged
2025-09-3013GUnity Biotechnology, Inc.
UNBX
ARCH Venture Fund VII, L.P.0
0.000%
0
(Unchanged)
Filing